Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique
Sponsor: Zeynep Kamil Maternity and Pediatric Research and Training Hospital
This observational or N/A phase trial investigates DNA Damage and Granulosa Cells and is currently ongoing. Zeynep Kamil Maternity and Pediatric Research and Training Hospital leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Oct 2024 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Sep 2022 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Zeynep Kamil Maternity and Pediatric Research and Training Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.